6MK.DEライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (29 4月 2024 @ 20:59):

Stats
本日の出来高	120.00
平均出来高	984.00
時価総額	309.49B
EPS	€0 ( 2024-04-24 )
次の収益日	( €0 ) 2024-05-28
Last Dividend	€0.730 ( 2023-09-14 )
Next Dividend	€0 ( N/A )
P/E	145.48
ATR14	€0.754 (0.62%)

Merck & Co Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Merck & Co Inc 財務諸表

Annual	2023
収益:	€60.12B
総利益:	€43.99B (73.17 %)
EPS:	€0.140

FY	2023
収益:	€60.12B
総利益:	€43.99B (73.17 %)
EPS:	€0.140

FY	2022
収益:	€59.28B
総利益:	€41.87B (70.63 %)
EPS:	€5.72

FY	2021
収益:	€48.70B
総利益:	€35.08B (72.02 %)
EPS:	€5.14

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0.690 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Merck & Co Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.55 - Stable (30.93%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.380	2009-12-11
Last Dividend	€0.730	2023-09-14
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	56	--
Total Paid Out	€28.56	--
Avg. Dividend % Per Year	0.00%	--
Score	4.6	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.55
Div. Directional Score	8.48	--

Next Divdend (Est)
(2024-07-01)

€0.745 Estimate 22.11 %

Dividend Stability

0.59 Average

Dividend Score

4.60

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TTK.DE	Ex Dividend Junior	2023-05-25	Annually	0.00%
DWD.DE	Ex Dividend Junior	2023-07-28	Quarterly	0.00%
MZX.DE	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
8TRA.DE	Ex Dividend Junior	2023-06-02	Annually	0.00%
XGR2.DE	Ex Dividend Junior	2023-06-08	Annually	0.00%
FPMB.DE	Ex Dividend King	2023-10-12	Quarterly	0.00%
PFE.DE	Ex Dividend Knight	2023-07-27	Quarterly	0.00%
ASME.DE	Ex Dividend Knight	2023-08-01	Semi-Annually	0.00%
HNR1.DE	Ex Dividend Junior	2023-05-04	Annually	0.00%
SDF.DE	Ex Dividend Junior	2023-05-11	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00607	1.500	9.88	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00342	1.200	9.89	10.00	[0 - 0.3]
returnOnEquityTTM	0.00888	1.500	-1.012	-1.519	[0.1 - 1]
payoutRatioTTM	20.40	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.252	0.800	8.74	6.99	[1 - 3]
quickRatioTTM	0.679	0.800	-0.713	-0.570	[0.8 - 2.5]
cashRatioTTM	0.266	1.500	9.63	10.00	[0.2 - 2]
debtRatioTTM	0.329	-1.500	4.52	-6.78	[0 - 0.6]
interestCoverageTTM	3.18	1.000	9.93	9.93	[3 - 30]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.61	2.00	8.20	10.00	[0 - 20]
debtEquityRatioTTM	0.933	-1.500	6.27	-9.40	[0 - 2.5]
grossProfitMarginTTM	0.732	1.000	1.138	1.138	[0.2 - 0.8]
operatingProfitMarginTTM	0.0598	1.000	-0.804	-0.804	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.371	1.000	9.05	9.05	[0.2 - 2]
assetTurnoverTTM	0.564	0.800	9.58	7.66	[0.5 - 2]
Total Score				10.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	915.59	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.00888	2.50	-0.651	-1.519	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.61	2.00	8.80	10.00	[0 - 30]
dividendYielPercentageTTM	2.27	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	20.40	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	46.09	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.216	1.000	7.09	0	[0.1 - 0.5]
Total Score				6.55

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.